BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20125043)

  • 21. Association of Inclusion of Medicare Advantage Patients in Hospitals' Risk-Standardized Readmission Rates, Performance, and Penalty Status.
    Panagiotou OA; Voorhies KR; Keohane LM; Kim D; Adhikari D; Kumar A; Rivera-Hernandez M; Rahman M; Gozalo P; Gutman R; Mor V; Trivedi AN
    JAMA Netw Open; 2021 Feb; 4(2):e2037320. PubMed ID: 33595661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The need for multiple measures of hospital quality: results from the Get with the Guidelines-Heart Failure Registry of the American Heart Association.
    Hernandez AF; Fonarow GC; Liang L; Heidenreich PA; Yancy C; Peterson ED
    Circulation; 2011 Aug; 124(6):712-9. PubMed ID: 21788585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
    Bhatia V; Bajaj NS; Sanam K; Hashim T; Morgan CJ; Prabhu SD; Fonarow GC; Deedwania P; Butler J; Carson P; Love TE; Kheirbek R; Aronow WS; Anker SD; Waagstein F; Fletcher R; Allman RM; Ahmed A
    Am J Med; 2015 Jul; 128(7):715-21. PubMed ID: 25554369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Readmissions and the quality of care in patients hospitalized with heart failure.
    Luthi JC; Lund MJ; Sampietro-Colom L; Kleinbaum DG; Ballard DJ; McClellan WM
    Int J Qual Health Care; 2003 Oct; 15(5):413-21. PubMed ID: 14527985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure.
    Heidenreich PA; Zhao X; Hernandez AF; Yancy CW; Fonarow GC
    Am Heart J; 2012 Feb; 163(2):239-45.e3. PubMed ID: 22305842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review and meta-analysis on the association between quality of hospital care and readmission rates in patients with heart failure.
    Fischer C; Steyerberg EW; Fonarow GC; Ganiats TG; Lingsma HF
    Am Heart J; 2015 Nov; 170(5):1005-1017.e2. PubMed ID: 26542511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of Performance and Outcome Measures for Heart Failure.
    Patel J; Sandhu A; Parizo J; Moayedi Y; Fonarow GC; Heidenreich PA
    Circ Heart Fail; 2018 Sep; 11(9):e005035. PubMed ID: 30354367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining the Utility of 30-day Readmission Rates and Hospital Profiling in the Veterans Health Administration.
    Wray CM; Vali M; Walter LC; Lopez L; Austin PC; Byers A; Keyhani S
    J Hosp Med; 2019 May; 14(5):266-271. PubMed ID: 30794141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional associations between Medicare Advantage penetration and administrative claims-based measures of hospital outcomes.
    Kulkarni VT; Shah SJ; Bernheim SM; Wang Y; Normand SL; Han LF; Rapp MT; Drye EE; Krumholz HM
    Med Care; 2012 May; 50(5):406-9. PubMed ID: 22456113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between process quality measures for heart failure and mortality among US veterans.
    Wu WC; Jiang L; Friedmann PD; Trivedi A
    Am Heart J; 2014 Nov; 168(5):713-20. PubMed ID: 25440800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.
    Gupta A; Allen LA; Bhatt DL; Cox M; DeVore AD; Heidenreich PA; Hernandez AF; Peterson ED; Matsouaka RA; Yancy CW; Fonarow GC
    JAMA Cardiol; 2018 Jan; 3(1):44-53. PubMed ID: 29128869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centers for Medicare and Medicaid Services' readmission reports inaccurately describe an institution's decompensated heart failure admissions.
    Cox ZL; Lai P; Lewis CM; Lenihan DJ
    Clin Cardiol; 2017 Sep; 40(9):620-625. PubMed ID: 28471510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.
    Hernandez AF; Hammill BG; O'Connor CM; Schulman KA; Curtis LH; Fonarow GC
    J Am Coll Cardiol; 2009 Jan; 53(2):184-92. PubMed ID: 19130987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between emerging measures of heart failure processes of care and clinical outcomes.
    Hernandez AF; Hammill BG; Peterson ED; Yancy CW; Schulman KA; Curtis LH; Fonarow GC
    Am Heart J; 2010 Mar; 159(3):406-13. PubMed ID: 20211302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
    Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
    JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is same-hospital readmission rate a good surrogate for all-hospital readmission rate?
    Nasir K; Lin Z; Bueno H; Normand SL; Drye EE; Keenan PS; Krumholz HM
    Med Care; 2010 May; 48(5):477-81. PubMed ID: 20393366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gaming hospital-level pneumonia 30-day mortality and readmission measures by legitimate changes to diagnostic coding.
    Sjoding MW; Iwashyna TJ; Dimick JB; Cooke CR
    Crit Care Med; 2015 May; 43(5):989-95. PubMed ID: 25746747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.